FREMONT, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Lam Research Corp. (Nasdaq:LRCX) today announced financial results for the quarter ended December 25, 2016 (the 'December 2016 quarter').

Highlights for the December 2016 quarter were as follows:

  • Shipments of $1.92 billion and revenue of $1.88 billion.
  • GAAP gross margin of 45.0%, GAAP operating margin of 23.4%, and GAAP diluted EPS of $1.81.
  • Non-GAAP gross margin of 46.4%, non-GAAP operating margin of 26.0%, and non-GAAP diluted EPS of $2.24.
Key Financial Data for the Quarters Ended
December 25, 2016 and September 25, 2016
(in thousands, except per-share data, percentages, and basis points)
U.S. GAAP
December 2016 September 2016 Change Q/Q
Shipments $ 1,922,549 $ 1,708,483 + 13 %
Revenue $ 1,882,299 $ 1,632,419 + 15 %
Gross margin as percentage of revenue 45.0 % 43.9 % + 110 bps
Operating margin as percentage of revenue 23.4 % 19.4 % + 400 bps
Diluted EPS $ 1.81 $ 1.47 + 23 %
Non-GAAP
December 2016 September 2016 Change Q/Q
Shipments $ 1,922,549 $ 1,708,483 + 13 %
Revenue $ 1,882,299 $ 1,632,419 + 15 %
Gross margin as percentage of revenue 46.4 % 45.2 % + 120 bps
Operating margin as percentage of revenue 26.0 % 22.4 % + 360 bps
Diluted EPS $ 2.24 $ 1.81 + 24 %

U.S. GAAP Financial Results

For the December 2016 quarter, revenue was $1,882 million, gross margin was $847 million, or 45.0% of revenue, operating expenses were $407 million, operating margin was 23.4% of revenue, and net income was $333 million, or $1.81 per diluted share on a GAAP basis. This compares to revenue of $1,632 million, gross margin of $716 million, or 43.9% of revenue, operating expenses of $400 million, operating margin of 19.4% of revenue, and net income of $264 million, or $1.47 per diluted share, for the quarter ended September 25, 2016 (the 'September 2016 quarter').

Non-GAAP Financial Results

For the December 2016 quarter, non-GAAP gross margin was $874 million or 46.4% of revenue, non-GAAP operating expenses were $384 million, non-GAAP operating margin was 26.0% of revenue, and non-GAAP net income was $405 million, or $2.24 per diluted share. This compares to non-GAAP gross margin of $737 million or 45.2% of revenue, non-GAAP operating expenses of $372 million, non-GAAP operating margin of 22.4% of revenue, and non-GAAP net income of $322 million, or $1.81 per diluted share for the September 2016 quarter.

'Lam delivered another record for shipments, revenue, and net income in December, concluding a fifth consecutive year of revenue growth and outperformance when compared against the overall wafer fab equipment industry,' said Martin Anstice, Lam Research's President and Chief Executive Officer. 'Lam's results occur through the hard work and commitment of our employees worldwide and the increasing strategic relevance and partnership established with our customers. Looking ahead to 2017, the combination of healthy end-demand in established business segments and new application drivers are setting the course for another year of industry growth and outperformance for Lam. We are inspired by the opportunity to deliver innovation to a transforming technology industry and semiconductor ecosystem.'

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $6.1 billion at the end of the December 2016 quarter compared to $7.5 billion at the end of the September 2016 quarter. This decrease was primarily the result of approximately $1.6 billion of cash payments for the settlement of debt, combined with approximately $37 million of capital expenditures; and approximately $48 million of dividends paid to stockholders, offset by $404 million in cash flows from operating activities during the December 2016 quarter.

Deferred revenue at the end of the December 2016 quarter decreased to $673 million as compared to $704 million at the end of the September 2016 quarter. Deferred profit at the end of the December 2016 quarter decreased to $408 million as compared to $418 million at the end of the September 2016 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to Japanese customers was approximately $129 million as of December 25, 2016 and $65 million as of September 25, 2016.

Geographic Distribution

The geographic distribution of shipments and revenue during the December 2016 quarter is shown in the following table:

RegionShipmentsRevenue
Taiwan 37 % 37 %
Korea 25 % 26 %
China 8 % 10 %
Japan 12 % 8 %
United States 8 % 7 %
Europe 6 % 7 %
Southeast Asia 4 % 5 %

Outlook

For the March 2017 quarter, Lam is providing the following guidance:

U.S. GAAP Reconciling Items Non-GAAP
Shipments $2.350 Billion +/- $75 Million - $2.350 Billion +/- $75 Million
Revenue $2.125 Billion +/- $75 Million - $2.125 Billion +/- $75 Million
Gross margin 44.5 % +/- 1 % $ 21 Million 45.5 % +/- 1 %
Operating margin 23.8 % +/- 1 % $ 37 Million 25.5 % +/- 1 %
Net income per diluted share $ 2.31 +/- $ 0.10 $ 37 Million $ 2.55 +/- $ 0.10
Diluted share count 183 Million 3 Million 180 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, balance sheet valuation adjustments, financing arrangements, other investments, or other significant transactions that may be completed or determined after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.
  • Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.
  • Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; amortization of note discounts, $6 million; and associated tax benefit for non-GAAP items ($6) million; totaling $37 million.
  • Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due 2018, 3 million shares.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the December 2016 and September 2016 quarters exclude amortization related to intangible assets acquired in the Novellus transaction, costs associated with campus consolidation, the amortization of note discounts, KLA-Tencor acquisition funding net interest expense and tax benefit of non-GAAP items. Additionally, the December 2016 quarter non-GAAP results exclude costs related to the early termination of the KLA-Tencor acquisition funding, product rationalization charges and litigation settlement and the September 2016 quarter non-GAAP results exclude KLA-Tencor acquisition-related charges.

Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers; our revenue and industry growth and performance outlooks and their drivers: our ability to transform atomic-scale engineering and enable our customers to shape the future of technology; the legal and business factors that may affect our future tax rate; and our guidance for shipments, revenue, gross margin, operating margin, net income or earnings per diluted share, and diluted share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; and the actions of our customers and competitors may be inconsistent with our expectations, as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 26, 2016 and our quarterly report on Form 10-Q for the period ended September 25, 2016. These uncertainties and changes could materially affect the forward looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

About Lam Research

Lam Research Corp. (Nasdaq:LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading deposition, etch, and clean solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, more powerful, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a Nasdaq-100 Index® and S&P 500® company whose common stock trades on the Nasdaq Global Select Market under the symbol LRCX. For more information, please visit http://www.lamresearch.com. (LRCX-F).

Consolidated Financial Tables Follow.

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
Three Months Ended Six Months Ended
December 25,
2016		 September 25,
2016		 December 27,
2015		 December 25,
2016		 December 27,
2015
Revenue $ 1,882,299 $ 1,632,419 $ 1,425,534 $ 3,514,718 $ 3,025,577
Cost of goods sold 1,035,502 916,222 799,024 1,951,724 1,676,704
Gross margin 846,797 716,197 626,510 1,562,994 1,348,873
Gross margin as a percent of revenue 45.0 % 43.9 % 43.9 % 44.5 % 44.6 %
Research and development 246,804 235,240 220,754 482,044 454,963
Selling, general and administrative 160,165 165,010 166,922 325,175 319,648
Total operating expenses 406,969 400,250 387,676 807,219 774,611
Operating income 439,828 315,947 238,834 755,775 574,262
Operating income as a percent of revenue 23.4 % 19.4 % 16.8 % 21.5 % 19.0 %
Other expense, net (55,023 ) (23,154 ) (29,935 ) (78,177 ) (57,056 )
Income before income taxes 384,805 292,793 208,899 677,598 517,206
Income tax (expense) benefit (52,014 ) (28,958 ) 14,081 (80,972 ) (5,547 )
Net income $ 332,791 $ 263,835 $ 222,980 $ 596,626 $ 511,659
Net income per share:
Basic $ 2.05 $ 1.64 $ 1.41 $ 3.69 $ 3.23
Diluted $ 1.81 $ 1.47 $ 1.28 $ 3.28 $ 2.94
Number of shares used in per share calculations:
Basic 162,659 160,607 158,424 161,633 158,388
Diluted 183,543 180,017 174,242 181,780 174,308
Cash dividend declared per common share $ 0.45 $ 0.30 $ 0.30 $ 0.75 $ 0.60
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
December 25,
2016		 September 25,
2016		 June 26,
2016
(unaudited) (unaudited) (1 )
ASSETS
Cash and cash equivalents $ 2,503,960 $ 5,861,701 $ 5,039,322
Investments 3,329,425 1,352,775 1,788,612
Accounts receivable, net 1,426,307 1,290,317 1,262,145
Inventories 1,018,891 931,581 971,911
Other current assets 225,291 162,628 151,160
Total current assets 8,503,874 9,599,002 9,213,150
Property and equipment, net 672,553 649,587 639,608
Restricted cash and investments 255,175 255,640 250,421
Goodwill and intangible assets 1,873,581 1,912,431 1,951,197
Other assets 215,876 219,702 209,939
Total assets $ 11,521,059 $ 12,636,362 $ 12,264,315
LIABILITIES AND STOCKHOLDERS' EQUITY
Current portion of convertible notes and capital leases $ 957,895 $ 952,999 $ 947,733
Other current liabilities 1,700,123 1,533,253 1,470,308
Total current liabilities 2,658,018 2,486,252 2,418,041
Long-term debt and capital leases 1,768,713 3,378,179 3,378,129
Income taxes payable 238,968 241,671 231,514
Other long-term liabilities 262,351 142,910 134,562
Total liabilities 4,928,050 6,249,012 6,162,246
Temporary equity, convertible notes 197,313 202,467 207,552
Stockholders' equity (2) 6,395,696 6,184,883 5,894,517
Total liabilities and stockholders' equity $ 11,521,059 $ 12,636,362 $ 12,264,315
(1 ) Derived from audited financial statements.
(2 ) Common shares issued and outstanding were 162,357 as of December 25, 2016, 161,706 as of September 25, 2016, and 160,201 as of June 26, 2016.
(3 ) Adjusted for effects of retrospective implementation of ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Three Months Ended Six Months Ended
December 25,
2016		 September 25,
2016		 December 27,
2015		 December 25,
2016		 December 27,
2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 332,791 $ 263,835 $ 222,980 $ 596,626 $ 511,659
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 77,065 74,562 71,798 151,627 142,388
Deferred income taxes 34,615 7,633 8,176 42,248 2,613
Equity-based compensation expense 32,255 38,595 32,570 70,850 68,344
Loss on extinguishment of debt 36,325 - - 36,325 -
Amortization of note discounts and issuance costs 6,202 6,830 23,649 13,032 33,480
Other, net (1,292 ) 16,807 10,579 15,515 20,563
Changes in operating assets and liabilities (113,863 ) 64,962 (75,207 ) (48,901 ) (35,505 )
Net cash provided by operating activities 404,098 473,224 294,545 877,322 743,542
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (36,513 ) (41,979 ) (28,143 ) (78,492 ) (77,597 )
Net (purchase) sale of available-for-sale securities (1,990,928 ) 431,750 39,202 (1,559,178 ) 10,999
(Issuance) repayment of notes receivable (500 ) - 8,082 (500 ) 8,082
Transfers of restricted cash and investments 465 (5,219 ) - (4,754 ) -
Other, net 259 (7,800 ) (4,746 ) (7,541 ) (6,246 )
Net cash (used for) provided by investing activities (2,027,217 ) 376,752 14,395 (1,650,465 ) (64,762 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs (1,616,270 ) (371 ) (28,374 ) (1,616,641 ) (28,470 )
Treasury stock purchases (67,668 ) (1,854 ) (12,798 ) (69,522 ) (111,183 )
Dividends paid (48,397 ) (48,052 ) (47,896 ) (96,449 ) (95,555 )
Reissuance of treasury stock related to employee stock purchase plan - 19,320 - 19,320 19,245
Proceeds from issuance of common stock 3,121 1,459 1,173 4,580 1,550
Other, net (44 ) (10 ) 2,159 (54 ) 5,431
Net cash used for financing activities (1,729,258 ) (29,508 ) (85,736 ) (1,758,766 ) (208,982 )
Effect of exchange rate changes on cash and cash equivalents (5,364 ) 1,911 344 (3,453 ) (3,464 )
Net (decrease) increase in cash and cash equivalents (3,357,741 ) 822,379 223,548 (2,535,362 ) 466,334
Cash and cash equivalents at beginning of period 5,861,701 5,039,322 1,744,325 5,039,322 1,501,539
Cash and cash equivalents at end of period $ 2,503,960 $ 5,861,701 $ 1,967,873 $ 2,503,960 $ 1,967,873
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
December 25,
2016		 September 25,
2016
Revenue $ 1,882,299 $ 1,632,419
Gross margin $ 874,174 $ 737,447
Gross margin as percentage of revenue 46.4 % 45.2 %
Operating expenses $ 384,241 $ 371,634
Operating income $ 489,933 $ 365,813
Operating margin as a percentage of revenue 26.0 % 22.4 %
Net income $ 405,190 $ 322,074
Net income per diluted share $ 2.24 $ 1.81
Shares used in per share calculation - diluted 180,613 177,628
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares
(in thousands, except per share data)
(unaudited)
Three Months Ended
December 25,
2016		 September 25,
2016
U.S. GAAP net income $ 332,791 $ 263,835
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold 21,250 21,250
Product rationalization - cost of goods sold 6,127 -
Costs associated with campus consolidation - research and development 995 2,561
Product rationalization - research and development 1,650 -
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative 16,083 16,083
KLA-Tencor acquisition-related costs - selling, general and administrative - 9,972
Litigation settlement - selling general and administrative 4,000 -
KLA-Tencor acquisition funding interest expense, net - other expense, net 2,682 17,709
Amortization of note discounts - other expense, net 5,671 5,913
Costs related to early termination of KLA-Tencor acquisition funding - other expense, net 34,518 -
Net income tax benefit on non-GAAP items (20,577 ) (15,249 )
Non-GAAP net income $ 405,190 $ 322,074
Non-GAAP net income per diluted share $ 2.24 $ 1.81
U.S. GAAP number of shares used for per diluted share calculation 183,543 180,017
Effect of convertible note hedge (2,930 ) (2,389 )
Non-GAAP number of shares used for per diluted share calculation 180,613 177,628
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Three Months Ended
December 25,
2016		 September 25,
2016
U.S. GAAP gross margin $ 846,797 $ 716,197
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired in Novellus transaction 21,250 21,250
Product rationalization $ 6,127 $ -
Non-GAAP gross margin $ 874,174 $ 737,447
U.S. GAAP gross margin as a percentage of revenue 45.0 % 43.9 %
Non-GAAP gross margin as a percentage of revenue 46.4 % 45.2 %
U.S. GAAP operating expenses $ 406,969 $ 400,250
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired in Novellus transaction (16,083 ) (16,083 )
KLA-Tencor acquisition-related costs - (9,972 )
Costs associated with campus consolidation (995 ) (2,561 )
Product rationalization (1,650 ) -
Litigation settlement (4,000 ) -
Non-GAAP operating expenses $ 384,241 $ 371,634
Non-GAAP operating income $ 489,933 $ 365,813
GAAP operating margin as percent of revenue 23.4 % 19.4 %
Non-GAAP operating margin as a percent of revenue 26.0 % 22.4 % 

Lam Research Corporation Contacts:

Satya Kumar, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

Source: Lam Research

News Provided by Acquire Media

Lam Research Corporation published this content on 25 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 09 February 2017 21:33:19 UTC.

Original documenthttp://investor.lamresearch.com/releasedetail.cfm?ReleaseID=1009145

Public permalinkhttp://www.publicnow.com/view/B347CE293D1155049D03F72F1F84BA4FA605F075